Commonplace
发表于 2025-3-30 11:50:05
http://reply.papertrans.cn/67/6692/669192/669192_51.png
Bone-Scan
发表于 2025-3-30 16:25:45
Marangoni Flows in a Cylindrical Liquid Bridge of Silicontween two solid sections of a Si crystal rod. The . σ created by the . θ (θ = temperature on the free surface S of B) generates Marangoni flow in B. We study this flow by numerically solving the time-dependent Navier-Stokes-energy system in B with “free” lateral surface S maintained by the balance between c and pressure p and with flat ends.
SEEK
发表于 2025-3-30 19:42:00
http://reply.papertrans.cn/67/6692/669192/669192_53.png
HEDGE
发表于 2025-3-31 00:32:15
http://reply.papertrans.cn/67/6692/669192/669192_54.png
TIA742
发表于 2025-3-31 04:46:41
Fine Mesh Solutions Using Stream Function-Vorticity FormulationResults for all the GAMM workshop test cases have been obtained by solving the equations in the stream function-vorticity formulation. An ADI scheme with a uniform square mesh was implemented. Several grids were tested for accuracy. Accurate solutions using a 81 × 321 grid are presented. A comparison of two and three-dimensional solutions is made.
指数
发表于 2025-3-31 06:50:23
Numerical Simulation of Oscillatory Convection in a Low Prandtl FluidA two-dimensional incompressible fluid analysis was carried out for Case A and Case C of the benchmark problems with using the finite difference method. This paper presents our solution method, calculated results and additional discussions concerning boundary treatment, time increment and allowable mass residual for the continuity equation.
Melanocytes
发表于 2025-3-31 10:36:37
http://reply.papertrans.cn/67/6692/669192/669192_57.png
轻快走过
发表于 2025-3-31 15:46:34
Numerical Simulation of Oscillatory Convection in Low-Pr Fluids978-3-322-87877-9Series ISSN 1612-2909 Series E-ISSN 1860-0824
contrast-medium
发表于 2025-3-31 18:50:31
http://reply.papertrans.cn/67/6692/669192/669192_59.png
Infantry
发表于 2025-3-31 23:45:32
H. Ben Hadid,B. Rouxtical enzyme in the steroid biosynthetic pathway that is very potently inhibited by etomidate. The goal of this chapter is to review the pharmacology of etomidate and to present recently published data obtained using novel etomidate analogues that were designed to have reduced impact on adrenocortical function.